Atterx

1 known investors

Atterx Biotherapeutics develops therapeutics to prevent and treat antibiotic-resistant bacterial infections, including drug candidates for Gram-negative infections (GN-4474) and catheter-associated urinary tract infections (C-1205). The company operates in the biotechnology and pharmaceutical sector focused on antimicrobial resistance.

BiotechHealthtech